Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.
暂无分享，去创建一个
David C. Smith | E. Basch | A. Bennett | H. Scher | J. Bono | C. Higano | D. Rathkopf | P. Corn | N. Vogelzang | D. George | C. Sweeney | A. Harzstark | M. Gordon | Matthew R. Smith | N. Haas | C. Scheffold | A. Weitzman | A. Sartor | K. Autio | F. Schimmoller